Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 1, 2004; 10(5): 649-653
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.649
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.649
Point | 0 | 1 |
Size of tumor | < 50% of liver | > 50 % |
Ascites | No | Yes |
Albumin | ≥ 3 | < 3 |
Bilirubin | < 3 | ≥ 3 |
Stage I: 0 | II: 1 or 2 | III: 3 or 4 |
- Citation: Wang TE, Kao CR, Lin SC, Chang WH, Chu CH, Lin J, Hsieh RK. Salvage therapy for hepatocellular carcinoma with thalidomide. World J Gastroenterol 2004; 10(5): 649-653
- URL: https://www.wjgnet.com/1007-9327/full/v10/i5/649.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i5.649